Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.

Watson NW, Bukhari S, Rashedi S, Pfeferman M, Ujueta F, Bacare B, Weber BN, Zarghami M, Kanthi Y, Secemsky EA, Connors JM, Barnes GD, Uljon S, Goldhaber SZ, Weitz JI, Costenbader KH, Krumholz HM, Piazza G, Cushman M, Anderson CD, Elkind MSV, Bikdeli B

Open source

DOI: 10.1161/strokeaha.126.055247
Published: 2026 Aug 28
Container: Stroke
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/strokeaha.126.055247,
  title = {Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.},
  author = {Watson NW and Bukhari S and Rashedi S and Pfeferman M and Ujueta F and Bacare B and Weber BN and Zarghami M and Kanthi Y and Secemsky EA and Connors JM and Barnes GD and Uljon S and Goldhaber SZ and Weitz JI and Costenbader KH and Krumholz HM and Piazza G and Cushman M and Anderson CD and Elkind MSV and Bikdeli B},
  year = {2026},
  journal = {Stroke},
  doi = {10.1161/strokeaha.126.055247},
  url = {https://doi.org/10.1161/strokeaha.126.055247}
}

RIS

TY  - JOUR
TI  - Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.
AU  - Watson NW
AU  - Bukhari S
AU  - Rashedi S
AU  - Pfeferman M
AU  - Ujueta F
AU  - Bacare B
AU  - Weber BN
AU  - Zarghami M
AU  - Kanthi Y
AU  - Secemsky EA
AU  - Connors JM
AU  - Barnes GD
AU  - Uljon S
AU  - Goldhaber SZ
AU  - Weitz JI
AU  - Costenbader KH
AU  - Krumholz HM
AU  - Piazza G
AU  - Cushman M
AU  - Anderson CD
AU  - Elkind MSV
AU  - Bikdeli B
PY  - 2026
JO  - Stroke
DO  - 10.1161/strokeaha.126.055247
UR  - https://doi.org/10.1161/strokeaha.126.055247
ER  -

APA

NW, W., S, B., S, R., M, P., F, U., B, B., BN, W., M, Z., Y, K., EA, S., JM, C., GD, B., S, U., SZ, G., JI, W., KH, C., HM, K., G, P., M, C., CD, A., MSV, E., & B, B. (2026). Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.. Stroke. https://doi.org/10.1161/strokeaha.126.055247

Source records

pubmed · retrieved 2026-09-24T23:14:53.119Z